Moneycontrol PRO

Sansaar

you are here: HomeNewsVideosBusinessMarketsEmerging opportunities can help re-rate Divi’s lab

SHOW NAMES

Trending Topics

Sensex Today Rail Vikas Nigam Share Price Cohance Life Shares Diamond Power Share Price

X

business

Emerging opportunities can help re-rate Divi’s lab

Divi’s Lab is a leading API manufacture of India, primarily known for its market share in molecules like naproxen, gabapentin, and dexamethrophan. While its performance in last few quarters has been impacted due to multiple headwinds, it is well positioned for the new earnings drivers like contrast media and completion of new facility next year

first published: Sep 1, 2023 01:16 pm

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347